xl-888 has been researched along with Skin-Neoplasms* in 1 studies
1 other study(ies) available for xl-888 and Skin-Neoplasms
Article | Year |
---|---|
XL888 Limits Vemurafenib-Induced Proliferative Skin Events by Suppressing Paradoxical MAPK Activation.
Topics: Azabicyclo Compounds; Biopsy, Needle; Cell Proliferation; Drug Interactions; Humans; Immunohistochemistry; Indoles; Melanoma; Mitogen-Activated Protein Kinase Kinases; Phthalic Acids; Sensitivity and Specificity; Skin; Skin Neoplasms; Sulfonamides; Tissue Culture Techniques; Vemurafenib | 2015 |